Prevalence and Outcome of Hypermetabolism in Initial Prevalence and Outcome of Hypermetabolism in Initial Phase of Intensive Care Unit Patient: a Prospective Observational Study
- Conditions
- SIRSSepsisSeptic Shock
- Registration Number
- NCT02002676
- Lead Sponsor
- Nanjing University School of Medicine
- Brief Summary
Patients in critical illness frequently present hypermetabolism, which can extremely increase the rest energy expenditure(REE). We hypothesize that if we alleviate the extremely increased REE will improve ICU patients' outcome
- Detailed Description
This study focuses on the early changes of REE of critical ill patients when they admitted to ICU.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 62
Inclusion Criteria
- Older than 18 year.
- APACHEⅡ score≥8
Exclusion Criteria
- Hypercortisolism
- Thyroid disease
- Tracheoesophageal fistula
- FiO2>60 or PEEP>12cm H2O in mechanical ventilate
- Pregnancy
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Mortality rate of 28 days From ICU admission to 28th days of observation
- Secondary Outcome Measures
Name Time Method Incidence of Multiple Organ Dysfunction Syndrome(MODS)in 60 days From ICU admission to 60th days of observation
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What metabolic pathways are associated with hypermetabolism in ICU patients with septic shock (NCT02002676)?
How does hypermetabolism management in NCT02002676 compare to standard nutritional support in sepsis patients?
Which biomarkers correlate with hypermetabolism severity and predict outcomes in SIRS patients?
What are the potential adverse events of targeting hypermetabolism in ICU patients and how are they managed?
Are there combination therapies or metabolic modulators that improve outcomes in sepsis-induced hypermetabolism?
Trial Locations
- Locations (1)
Nanjing University School of Medicine
🇨🇳Nanjing, Jiangsu, China
Nanjing University School of Medicine🇨🇳Nanjing, Jiangsu, ChinaChao Wu, Ph.D.Contact008615005171483wuchao0008@126.com